![]() |
市場調查報告書
商品編碼
1833649
手術手套市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測Surgical Gloves Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球手術手套市場價值為 8.811 億美元,預計將以 12.4% 的複合年成長率成長,到 2034 年達到 29 億美元。
已開發地區和新興地區醫療保健支出的增加、外科手術的增多以及對現代醫院基礎設施的持續投資推動了市場擴張。感染預防意識的增強和對嚴格安全標準的遵守進一步刺激了需求。手套生產技術的進步,尤其是無粉和無乳膠替代品的採用,正在解決過敏問題,同時提高靈敏度、舒適度和耐用性。全球和地區衛生當局實施的監管框架確保符合嚴格的品質基準,增強了人們對使用外科手套的信任。亞太地區和拉丁美洲醫療保健可近性的擴大,加上全球對永續和環保材料的趨勢,正在為製造商帶來新的機會。這些發展共同凸顯了安全、創新和不斷發展的醫療保健服務體系如何塑造外科手套作為全球醫療實踐重要組成部分的作用。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 8.811億美元 |
預測值 | 29億美元 |
複合年成長率 | 12.4% |
2024年,合成手套市場佔了65.1%的佔有率,這得益於市場對無乳膠手套的需求,不僅能最大限度地降低過敏風險,還能提供耐化學性和耐用性。氯丁橡膠、丁腈橡膠和聚異戊二烯等合成材料因其卓越的防穿刺性能和耐用性,擴大應用於複雜、長時間的手術。
2024年,丁腈手套市場規模達到4.282億美元,憑藉其在耐化學性、低致敏性以及對抗血源性病原體和細胞毒性藥物方面的卓越表現,佔據了主導地位。由於職業健康的考量,丁腈手套比乳膠手套更受青睞,在骨科和腫瘤科等高風險外科手術領域的應用日益廣泛。
2024年,美國手術手套市場規模達2.527億美元,這得益於先進的醫療基礎設施、不斷成長的手術需求以及日益轉向丁腈和永續手套的選擇。成熟製造商積極投資於產品開發和創新,持續增強了美國國內市場前景。
影響全球手術手套市場的關鍵參與者包括 MEDLINE、TOP GLOVE、Semperit AG Holding、Ansell、SUPERMAX CORPORATION BERHAD、Hartalega、INTCO Medical、Cardinal Health、Kossan Rubber Industries 和 GLOBUS。為了鞏固其在手術手套行業的地位,領先公司正在推行多種策略。研發投資旨在提高手套的性能、耐用性和舒適度,同時利用先進的合成材料解決過敏風險。企業也注重永續的生產實踐,引入環保和可生物分解的方案,以實現全球環境目標。擴大新興經濟體的產能是另一個關鍵途徑,可確保成本效益和更廣泛的市場滲透。與醫療保健提供者和分銷商的合作有助於企業確保穩定的需求並增強供應鏈的可靠性。
The Global Surgical Gloves Market was valued at USD 881.1 million in 2024 and is estimated to grow at a CAGR of 12.4% to reach USD 2.9 billion by 2034.
Market expansion is supported by increasing healthcare expenditure, rising surgical procedures, and continuous investments in modern hospital infrastructure across developed and emerging regions. Heightened awareness of infection prevention and adherence to strict safety standards are further stimulating demand. Technological progress in glove production, particularly the adoption of powder-free and latex-free alternatives, is addressing allergy concerns while improving sensitivity, comfort, and durability. Regulatory frameworks enforced by global and regional health authorities ensure compliance with strict quality benchmarks, driving trust in the adoption of surgical gloves. Expanding healthcare access in Asia-Pacific and Latin America, coupled with global trends toward sustainable and eco-conscious materials, is opening new opportunities for manufacturers. Together, these developments underscore how safety, innovation, and evolving healthcare delivery systems are shaping the role of surgical gloves as an essential part of medical practice worldwide.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $881.1 Million |
Forecast Value | $2.9 Billion |
CAGR | 12.4% |
The synthetic segment held a 65.1% share in 2024, supported by demand for latex-free gloves that minimize allergy risks while offering chemical resistance and durability. Synthetic options such as neoprene, nitrile, and polyisoprene are increasingly chosen for complex, long-duration surgeries due to their superior puncture protection and durability.
The nitrile gloves segment generated USD 428.2 million in 2024, establishing dominance with its strength in chemical resistance, hypoallergenic properties, and effectiveness against bloodborne pathogens and cytotoxic agents. Nitrile gloves are widely preferred over latex because of occupational health concerns, with growing use in high-risk surgical fields, including orthopedic and oncology procedures.
U.S. Surgical Gloves Market was valued at USD 252.7 million in 2024, driven by advanced medical infrastructure, rising surgical demand, and a growing shift toward nitrile and sustainable glove options. The presence of established manufacturers actively investing in product development and innovation continues to strengthen the domestic market outlook.
Key players shaping the Global Surgical Gloves Market include MEDLINE, TOP GLOVE, Semperit AG Holding, Ansell, SUPERMAX CORPORATION BERHAD, Hartalega, INTCO Medical, Cardinal Health, Kossan Rubber Industries, and GLOBUS. To reinforce their position in the surgical gloves industry, leading companies are pursuing multiple strategies. R&D investments are aimed at improving glove performance, durability, and comfort while addressing allergy risks with advanced synthetic materials. Firms are also focusing on sustainable production practices, introducing eco-friendly and biodegradable options to meet global environmental goals. Expanding manufacturing capacity in emerging economies is another key approach, ensuring cost efficiency and broader market penetration. Partnerships with healthcare providers and distributors help companies secure consistent demand and strengthen supply chain reliability.